SEC Form 4 · accession 0001193125-26-259520
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen D. Griffin
Officer — President and CEO · Director
Period of report
Jun 3, 2026
Accepted (ET)
Jun 5, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 3, 2026 | M | 12,840 | — | A | 49,742 | D | |
| Common StockF3 | Jun 3, 2026 | F | 3,769 | $14.41 | D | 45,973 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F4 | — | Jun 3, 2026 | M | 12,840 | D | — | — | Common Stock | 12,840 | 12,840 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
- F2Includes 739 shares acquired on May 14, 2026 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan.
- F3Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2026.
- F4On June 3, 2024, the Reporting Person was granted 38,520 RSUs vesting in three equal annual installments beginning on June 3, 2025. This transaction reflects the second vesting installment of such RSU award.